Antony A. Cooper

6.3k total citations · 3 hit papers
43 papers, 4.9k citations indexed

About

Antony A. Cooper is a scholar working on Molecular Biology, Neurology and Cell Biology. According to data from OpenAlex, Antony A. Cooper has authored 43 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 20 papers in Neurology and 14 papers in Cell Biology. Recurrent topics in Antony A. Cooper's work include Parkinson's Disease Mechanisms and Treatments (20 papers), Cellular transport and secretion (12 papers) and Fungal and yeast genetics research (11 papers). Antony A. Cooper is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (20 papers), Cellular transport and secretion (12 papers) and Fungal and yeast genetics research (11 papers). Antony A. Cooper collaborates with scholars based in Australia, United States and New Zealand. Antony A. Cooper's co-authors include Cole M. Haynes, Tom H. Stevens, Kathryn J. Hill, Aaron D. Gitler, Kim A. Caldwell, Katherine E. Strathearn, Jean‐Christophe Rochet, Guy A. Caldwell, Susan Lindquist and Margaret M. Kincaid and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Antony A. Cooper

42 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models

2006 1.1k citations Antony A. Cooper, Aaron D. Gitler et al. Science profile →
Degradation of Misfolded Proteins Prevents ER-Derived Oxidative Stress and Cell Death

2004 531 citations Cole M. Haynes, Antony A. Cooper et al. Molecular Cell profile →
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease

2014 382 citations Karen E. Murphy, Amanda M. Gysbers et al. Brain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antony A. Cooper Australia	26	2.5k	2.2k	1.8k	1.2k	815	43	4.9k
Lih‐Shen Chin United States	40	4.0k 1.6×	1.7k 0.8×	1.7k 1.0×	1.2k 1.0×	947 1.2×	70	6.7k
Wanli W. Smith United States	30	2.4k 1.0×	809 0.4×	2.6k 1.5×	1.2k 1.0×	546 0.7×	70	5.1k
Panaiyur S. Mohan United States	31	1.9k 0.8×	1.7k 0.8×	688 0.4×	2.3k 1.9×	1.7k 2.1×	44	5.1k
Mervyn J. Monteiro United States	36	2.3k 0.9×	1.1k 0.5×	841 0.5×	769 0.6×	519 0.6×	74	3.7k
Qian Cai United States	35	2.5k 1.0×	1.1k 0.5×	592 0.3×	1.4k 1.2×	1.3k 1.6×	55	4.5k
Bingwei Lu United States	48	4.9k 2.0×	1.7k 0.8×	2.5k 1.4×	1.7k 1.4×	1.4k 1.7×	101	8.0k
Sara Imarisio United Kingdom	24	2.4k 1.0×	1.6k 0.8×	1.2k 0.7×	1.3k 1.1×	2.7k 3.3×	32	5.7k
Wolfdieter Springer United States	29	2.9k 1.2×	715 0.3×	2.0k 1.1×	984 0.8×	2.5k 3.1×	58	5.3k
Marta Martínez‐Vicente Spain	32	3.1k 1.2×	1.7k 0.8×	2.1k 1.2×	2.7k 2.3×	3.5k 4.3×	47	7.6k
Kathryn J. Hill United States	19	1.6k 0.6×	845 0.4×	1.1k 0.6×	613 0.5×	313 0.4×	26	3.0k

Countries citing papers authored by Antony A. Cooper

Since Specialization

Citations

This map shows the geographic impact of Antony A. Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony A. Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony A. Cooper more than expected).

Fields of papers citing papers by Antony A. Cooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony A. Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony A. Cooper. The network helps show where Antony A. Cooper may publish in the future.

Co-authorship network of co-authors of Antony A. Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Antony A. Cooper. A scholar is included among the top collaborators of Antony A. Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony A. Cooper. Antony A. Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cooper, Antony A., et al.. (2025). From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease. Journal of Parkinson s Disease. 15(2). 255–268. 1 indexed citations

Lewis, Simon J.G., Carolyn M. Sue, Antony A. Cooper, & Glenda M. Halliday. (2025). Future is now: an Australasian perspective on disease-modifying trials in Parkinson’s and prodromal disease. BMJ Neurology Open. 7(1). e001070–e001070.

Fadason, Tayaza, et al.. (2024). Discovering genetic mechanisms underlying the co-occurrence of Parkinson’s disease and non-motor traits. npj Parkinson s Disease. 10(1). 27–27. 3 indexed citations

Schierding, William, et al.. (2024). Identification of 27 allele-specific regulatory variants in Parkinson’s disease using a massively parallel reporter assay. npj Parkinson s Disease. 10(1). 44–44. 5 indexed citations

Hill, Kathryn J., et al.. (2022). Single Molecule Fingerprinting Reveals Different Amplification Properties of α-Synuclein Oligomers and Preformed Fibrils in Seeding Assay. ACS Chemical Neuroscience. 13(7). 883–896. 11 indexed citations

Cooper, Antony A., et al.. (2022). Redefining the hypotheses driving Parkinson’s diseases research. npj Parkinson s Disease. 8(1). 45–45. 15 indexed citations

Schierding, William, et al.. (2022). Establishing gene regulatory networks from Parkinson’s disease risk loci. Brain. 145(7). 2422–2435. 10 indexed citations

Zhang, J. Diana, et al.. (2022). Identifying robust and reliable volatile organic compounds in human sebum for biomarker discovery. Analytica Chimica Acta. 1233. 340506–340506. 9 indexed citations

Schierding, William, et al.. (2022). Machine Learning Identifies Six Genetic Variants and Alterations in the Heart Atrial Appendage as Key Contributors to PD Risk Predictivity. Frontiers in Genetics. 12. 785436–785436. 6 indexed citations

10.

Schierding, William, Tayaza Fadason, Toni L. Pitcher, et al.. (2020). Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset. Movement Disorders. 35(8). 1346–1356. 21 indexed citations

11.

Kong, Stephanie M.Y., Jin‐Sung Park, Kathryn J. Hill, et al.. (2014). Parkinson's disease-linked human PARK9/ATP13A2 maintains zinc homeostasis and promotes α-Synuclein externalization via exosomes. Human Molecular Genetics. 23(11). 2816–2833. 188 indexed citations

12.

Murphy, Karen E., Amanda M. Gysbers, Sarah K. Abbott, et al.. (2014). Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease. Brain. 137(3). 834–848. 382 indexed citations breakdown →

13.

Chesi, Alessandra, Austin S. Kilaru, Xiaodong Fang, Antony A. Cooper, & Aaron D. Gitler. (2012). The Role of the Parkinson's Disease Gene PARK9 in Essential Cellular Pathways and the Manganese Homeostasis Network in Yeast. PLoS ONE. 7(3). e34178–e34178. 42 indexed citations

14.

Cooper, Antony A., Aaron D. Gitler, Anil G. Cashikar, et al.. (2006). α-Synuclein Blocks ER-Golgi Traffic and Rab1 Rescues Neuron Loss in Parkinson's Models. Science. 313(5785). 324–328. 1064 indexed citations breakdown →

15.

Kincaid, Margaret M. & Antony A. Cooper. (2006). Misfolded Proteins Traffic from the Endoplasmic Reticulum (ER) Due to ER Export Signals. Molecular Biology of the Cell. 18(2). 455–463. 90 indexed citations

16.

Haynes, Cole M., et al.. (2004). Degradation of Misfolded Proteins Prevents ER-Derived Oxidative Stress and Cell Death. Molecular Cell. 15(5). 767–776. 531 indexed citations breakdown →

17.

Haynes, Cole M., et al.. (2002). An HRD / DER -independent ER quality control mechanism involves Rsp5p-dependent ubiquitination and ER-Golgi transport. The Journal of Cell Biology. 158(1). 91–102. 107 indexed citations

18.

Hill, Kathryn J., et al.. (2001). Degradation of Endoplasmic Reticulum (ER) Quality Control Substrates Requires Transport between the ER and Golgi. Journal of Biological Chemistry. 276(26). 23296–23303. 154 indexed citations

19.

Hill, Kathryn J. & Antony A. Cooper. (2000). Degradation of unassembled Vph1p reveals novel aspects of the yeast ER quality control system. The EMBO Journal. 19(4). 550–561. 93 indexed citations

20.

Cooper, Antony A.. (1995). Protein splicing: self-splicing of genetically mobile elements at the protein level. Trends in Biochemical Sciences. 20(9). 351–356. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact